🇺🇸 FDA
Patent

US 11061094

Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)

granted A61KA61K49/105

Quick answer

US patent 11061094 (Simultaneous pH and oxygen weighted MRI contrast using multi-echo chemical exchange saturation transfer imaging (ME-CEST)) held by The Regents of the University of California expires Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K49/105